Works matching DE "DRUG therapy for Parkinson's disease"

Results: 829

Trends of Korean Medicine Treatment for Parkinson's Disease in South Korea: A Cross-Sectional Analysis Using the Health Insurance Review and Assessment Service–National Patient Sample Database.

Published in:

Healthcare (2227-9032), 2025, v. 13, n. 10, p. 1207, doi. 10.3390/healthcare13101207

By:

Kim, BackJun;
Kim, Huijun;
Lee, Ye-Seul;
Lee, Yoon Jae;
Jung, In Chul;
Kim, Ju Yeon;
Ha, In-Hyuk

Publication type:

Article

Patterns of Use and Patient‐Reported Effects of Cannabinoids in People With PD: A Nationwide Survey.

Published in:

Parkinson's Disease (20420080), 2025, v. 2025, p. 1, doi. 10.1155/padi/2979089

By:

Barré, Tangui;
Cazorla, Géraldine;
Di Beo, Vincent;
Lopez, Fabienne;
Radoszycki, Lise;
Maradan, Gwenaëlle;
Baunez, Christelle;
Carrieri, Patrizia;
Jha, Poulami

Publication type:

Article

Artemisiae Iwayomogii Herba Protects Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity in Models of Parkinson's Disease.

Published in:

Nutrients, 2025, v. 17, n. 10, p. 1672, doi. 10.3390/nu17101672

By:

Lee, Hanbyeol;
Ju, In Gyoung;
Kim, Jin Hee;
Choi, Yujin;
Lee, Seungmin;
Park, Hi-Joon;
Oh, Myung Sook

Publication type:

Article

The Influence of on Levodopa-Induced Dyskinesia.

Published in:

2022

By:

Ari, Buse;
Domac, Fusun;
Kenangil, Gulay;
Imamova, Nergis;
Kuskucu, Aysegul;
Ari, Buse Cagla;
Domac, Fusun Mayda;
Kenangil, Gulay Ozgen;
Kuskucu, Aysegul Cinar

Publication type:

Journal Article

Levodopa-Induced Dyskinesias Related to Ingestion in a Parkinson's Disease Patient.

Published in:

2021

By:

Lambea-Gil, Alvaro;
María-Ángeles;
Requena-Calleja;
Horna-Cañete, Laura

Publication type:

Letter

Teleost Model as an Alternative in Parkinson's Disease.

Published in:

2020

By:

Manasa, K;
Chitra, V;
Tamilanban, T

Publication type:

journal article

Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.

Published in:

2018

By:

Lenka, Abhishek;
Jhunjhunwala, Ketan;
Stezin, Albert;
Manjunath, M;
Srinivas, Dwarakanath;
Yadav, Ravi;
Pal, Pramod;
Jhunjhunwala, Ketan R;
Pal, Pramod K

Publication type:

Case Study

Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 289, doi. 10.1007/s00228-022-03438-4

By:

Oonk, N. G. M.;
Dorresteijn, L. D. A.;
van den Berg, A. D.;
van der Palen, J.;
Movig, K. L. L.;
Nijmeijer, H. W.;
van Kesteren, M. E.;
Koffijberg, H.

Publication type:

Article

Case report: cold medicines cause neuroleptic malignant-like syndrome in a patient with Parkinson's disease.

Published in:

2022

By:

JiYi, Xu;
Hantao, Song;
Lijiao, Zhao;
Bin, Qin

Publication type:

Case Study

Safety and efficacy of tolcapone in Parkinson's disease: systematic review.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 6, p. 817, doi. 10.1007/s00228-020-03081-x

By:

Artusi, Carlo Alberto;
Sarro, Lidia;
Imbalzano, Gabriele;
Fabbri, Margherita;
Lopiano, Leonardo

Publication type:

Article

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 12, p. 1731, doi. 10.1007/s00228-020-02961-6

By:

Binde, Caroline D.;
Tvete, Ingunn F.;
Gåsemyr, Jørund I.;
Natvig, Bent;
Klemp, Marianne

Publication type:

Article

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1299, doi. 10.1007/s00228-018-2497-2

By:

Senek, Marina;
Nyholm, Dag;
Nielsen, Elisabet I.

Publication type:

Article

Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 563, doi. 10.1007/s00228-017-2196-4

By:

Senek, Marina;
Aquilonius, Sten-Magnus;
Askmark, Håkan;
Bergquist, Filip;
Constantinescu, Radu;
Ericsson, Anders;
Lycke, Sara;
Medvedev, Alexander;
Memedi, Mevludin;
Ohlsson, Fredrik;
Spira, Jack;
Westin, Jerker;
Nyholm, Dag

Publication type:

Article

A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 423, doi. 10.1007/s00228-016-2034-0

By:

Simon, N.;
Viallet, F.;
Boulamery, A.;
Eusebio, A.;
Gayraud, D.;
Azulay, J-P.

Publication type:

Article

Anticholinergic burden in Parkinson's disease inpatients.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 10, p. 1271, doi. 10.1007/s00228-015-1919-7

By:

Lertxundi, Unax;
Isla, Arantxazu;
Solinis, Maria Angeles;
Domingo-Echaburu, Saioa;
Hernandez, Rafael;
Peral-Aguirregoitia, Javier;
Medrano, Juan

Publication type:

Article

Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 1011, doi. 10.1007/s00228-015-1881-4

By:

Crispo, James;
Fortin, Yannick;
Thibault, Dylan;
Emons, Matthew;
Bjerre, Lise;
Kohen, Dafna;
Perez-Lloret, Santiago;
Mattison, Donald;
Willis, Allison;
Krewski, Daniel

Publication type:

Article

Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 12, p. 1471, doi. 10.1007/s00228-014-1772-0

By:

Lutz, Ulrich;
Sirfy, Ahmad;
Wiatr, Gerlinde;
Altpaß, Danuta;
Farger, Gisbert;
Gasser, Thomas;
Karle, Kathrin;
Batra, Anil

Publication type:

Article

Preladenant, a selective adenosine A receptor antagonist, is not associated with QT/QTc prolongation.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 10, p. 1761, doi. 10.1007/s00228-013-1541-5

By:

Wang, Z.;
Xuan, F.;
Lin, W.;
Troyer, M.;
Tendolkar, A.;
Cutler, D.

Publication type:

Article

Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol- O-methyltransferase inhibitors in Parkinson's disease patients.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1493, doi. 10.1007/s00228-012-1281-y

By:

Ferrari, Marco;
Martignoni, Emilia;
Blandini, Fabio;
Riboldazzi, Giulio;
Bono, Giorgio;
Marino, Franca;
Cosentino, Marco

Publication type:

Article

Do Parkinson's disease patients disclose their adverse events spontaneously?

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 857, doi. 10.1007/s00228-011-1198-x

By:

Perez-Lloret, Santiago;
Rey, María;
Fabre, Nelly;
Ory, Fabienne;
Spampinato, Umberto;
Montastruc, Jean-Louis;
Rascol, Olivier

Publication type:

Article

Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 1, p. 83, doi. 10.1007/s00228-011-1084-6

By:

Arbouw, Maurits;
Movig, Kris;
Guchelaar, Henk-Jan;
Neef, Cees;
Egberts, Toine

Publication type:

Article

Gene cloning and overproduction of low-specificity d-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug.

Published in:

Applied Microbiology & Biotechnology, 2000, v. 54, n. 1, p. 44, doi. 10.1007/s002539900301

By:

Liu, J. Q.;
Odani, M.;
Yasuoka, T.;
Dairi, T.;
Itoh, N.;
Kataoka, M.;
Shimizu, S.;
Yamada, H.

Publication type:

Article

A Case of DNAJC12 -Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early Detection.

Published in:

International Journal of Neonatal Screening (IJNS), 2024, v. 10, n. 1, p. 7, doi. 10.3390/ijns10010007

By:

Donnelly, Colleen;
Estrella, Lissette;
Ginevic, Ilona;
Ganesh, Jaya

Publication type:

Article

Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress.

Published in:

BMC Complementary Medicine & Therapies, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12906-022-03524-1

By:

Nourmohammadi, Saeideh;
Yousefi, Sanaz;
Manouchehrabadi, Mahboubeh;
Farhadi, Mona;
Azizi, Zahra;
Torkaman-Boutorabi, Anahita

Publication type:

Article

Parkinson's disease: considerations for dental hygienists.

Published in:

International Journal of Dental Hygiene, 2013, v. 11, n. 1, p. 15, doi. 10.1111/j.1601-5037.2012.00548.x

By:

DeBowes, SL;
Tolle, SL;
Bruhn, AM

Publication type:

Article

Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.

Published in:

Physiotherapy Research International, 2016, v. 21, n. 1, p. 36, doi. 10.1002/pri.1615

By:

Smith, Beth A.;
Carlson‐Kuhta, Patricia;
Horak, Fay B.

Publication type:

Article

Sublingual apomorphine therapy as an alternative to complex continuous infusion pumps in advanced Parkinson's disease treatment: a district nurse-led intervention.

Published in:

British Journal of Community Nursing, 2022, v. 27, n. 7, p. 328, doi. 10.12968/bjcn.2022.27.7.328

By:

Macaulay, Karis

Publication type:

Article

The importance of community nurses in supporting Parkinson's patients on complex therapies.

Published in:

British Journal of Community Nursing, 2022, v. 27, n. 2, p. 90, doi. 10.12968/bjcn.2022.27.2.90

By:

Peel, Charlie;
Thomas, Sue

Publication type:

Article

A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia.

Published in:

Dementia & Geriatric Cognitive Disorders, 2018, v. 45, n. 3/4, p. 131, doi. 10.1159/000486546

By:

Knight, Ruth;
Magill, Nicholas;
Landau, Sabine;
Khondoker, Mizanur;
Stewart, Robert

Publication type:

Article

Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study.

Published in:

Dementia & Geriatric Cognitive Disorders, 2018, v. 44, n. 5/6, p. 283, doi. 10.1159/000484437

By:

Gatt, ariana;
Ekonomou, antigoni;
Somani, alyma;
Thuret, Sandrine;
Howlett, David;
Corbett, anne;
Johnson, Mary;
Perry, Elaine;
attems, Johannes;
Francis, Paul;
aarsland, Dag;
Ballard, Clive

Publication type:

Article

Parkinson's disease at end of life: a guide for community nurses.

Published in:

Journal of Community Nursing, 2025, v. 39, n. 2, p. 56

By:

Bartlett, Victoria

Publication type:

Article

Study on the improvement of behavior and pain and the mechanism of Yangpafang in subacute Parkinson's disease model mice.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2024, v. 24, n. 12, p. 1036, doi. 10.3969/j.issn.1672-6731.2024.12.011

By:

SHI Ying;
MEI Shan-shan;
WANG Yuan-ling;
XIA A-long;
WANG Xiao-wei;
LI Jun

Publication type:

Article

Advance on association between 5-hydroxytryptamine and non- motor symptoms in Parkinson's disease.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2024, v. 24, n. 6, p. 497, doi. 10.3969/j.issn.1672-6731.2024.06.013

By:

SHI Ruo-lin;
GAO Xiu-jie;
CUI Jia-ning;
SHAO Yan;
XIE Lu-shuang;
LIU Yi

Publication type:

Article

Impact of initial treatment on future symptoms and quality of life in Parkinson's disease.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2022, v. 22, n. 4, p. 278, doi. 10.3969/j.issn.1672-6731.2022.04.009

By:

LI Yu-wang;
DONG Meng;
CHEN Xue-jiao;
WANG Min;
LI Xin;
CHEN Lei

Publication type:

Article

New advance for disease modification therapy in Parkinson's disease.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2022, v. 22, n. 3, p. 147, doi. 10.3969/j.issn.1672-6731.2022.03.005

By:

OU Ru-wei;
SHANG Hui-fang

Publication type:

Article

Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's Disease.

Published in:

Drugs, 2020, v. 80, n. 8, p. 775, doi. 10.1007/s40265-020-01310-2

By:

Vijiaratnam, Nirosen;
Foltynie, Thomas

Publication type:

Article

Levodopa Inhalation Powder: A Review in Parkinson's Disease.

Published in:

Drugs, 2020, v. 80, n. 8, p. 821, doi. 10.1007/s40265-020-01307-x

By:

Paik, Julia

Publication type:

Article

Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease.

Published in:

Drugs, 2019, v. 79, n. 15, p. 1709, doi. 10.1007/s40265-019-01201-1

By:

Hoy, Sheridan M.

Publication type:

Article

Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia.

Published in:

Drugs, 2019, v. 79, n. 13, p. 1367, doi. 10.1007/s40265-019-01170-5

By:

Müller, Thomas;
Möhr, Jan-Dominique

Publication type:

Article

Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.

Published in:

Drugs, 2019, v. 79, n. 10, p. 1037, doi. 10.1007/s40265-019-01139-4

By:

Zhao, Ye;
Dzamko, Nicolas

Publication type:

Article

Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.

Published in:

Drugs, 2019, v. 79, n. 8, p. 797, doi. 10.1007/s40265-019-01104-1

By:

Savitt, Daniel;
Jankovic, Joseph

Publication type:

Article

Are All Dopamine Agonists Essentially the Same?

Published in:

Drugs, 2019, v. 79, n. 7, p. 693, doi. 10.1007/s40265-019-01103-2

By:

Torti, Margherita;
Bravi, Daniele;
Vacca, Laura;
Stocchi, Fabrizio

Publication type:

Article

Medical Use of Cannabinoids.

Published in:

Drugs, 2018, v. 78, n. 16, p. 1665, doi. 10.1007/s40265-018-0996-1

By:

Fraguas-Sánchez, Ana Isabel;
Torres-Suárez, Ana Isabel

Publication type:

Article

Correction to: Opicapone: A Review in Parkinson's Disease.

Published in:

Drugs, 2018, v. 78, n. 1, p. 153, doi. 10.1007/s40265-017-0847-5

By:

Scott, Lesley

Publication type:

Article

Erratum to: Opicapone: A Review in Parkinson's Disease.

Published in:

Drugs, 2016, v. 76, n. 15, p. 1505, doi. 10.1007/s40265-016-0637-5

By:

Scott, Lesley

Publication type:

Article

Opicapone: A Review in Parkinson's Disease.

Published in:

Drugs, 2016, v. 76, n. 13, p. 1293, doi. 10.1007/s40265-016-0623-y

By:

Scott, Lesley

Publication type:

Article

Pimavanserin: First Global Approval.

Published in:

Drugs, 2016, v. 76, n. 10, p. 1053, doi. 10.1007/s40265-016-0597-9

By:

Markham, Anthony

Publication type:

Article

Disease-Modifying Drugs in Parkinson's Disease.

Published in:

Drugs, 2015, v. 75, n. 18, p. 2065, doi. 10.1007/s40265-015-0497-4

By:

Park, Ariane;
Stacy, Mark

Publication type:

Article

Safinamide: First Global Approval.

Published in:

2015

By:

Deeks, Emma

Publication type:

Journal Article

An Update on Pharmacological, Pharmacokinetic Properties and Drug-Drug Interactions of Rotigotine Transdermal System in Parkinson's Disease and Restless Legs Syndrome.

Published in:

2015

By:

Elshoff, Jan-Peer;
Cawello, Willi;
Andreas, Jens-Otto;
Mathy, Francois-Xavier;
Braun, Marina

Publication type:

Journal Article